SavedAdd your journal

Journals / Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi / 2014 / Cilt: 47 - Sayı: 2

NÖROMİYELİTİS OPTİKA

NEUROMYELITIS OPTICA

H. Nalan GÜNEŞ
Burcu Gökçe ÇAKAL
Tahir Kurtuluş YOLDAŞ
Pages
31–36
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It is important to distinguish NMO from other demyelinating diseases and multiple sclerosis (MS) because they have different course,prognosis and management.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Neuromyelitis optica (NMO) is an idiopathic inflammatory demyelinating disease characterized by involvement of the optic nerves and spinal cord.
📊
Key Findings & Data:It is caused by antibodies that attack a protein water channel aquaporin-4 (AQP-4) in astrocytic foot processes.
💡
Conclusion & Impact:It is important to distinguish NMO from other demyelinating diseases and multiple sclerosis (MS) because they have different course,prognosis and management.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Neuromyelitis optica (NMO) is an idiopathic inflammatory demyelinating disease characterized by involvement of the optic nerves and spinal cord. It is caused by antibodies that attack a protein water channel aquaporin-4 (AQP-4) in astrocytic foot processes. It is important to distinguish NMO from other demyelinating diseases and multiple sclerosis (MS) because they have different course,prognosis and management.

Özet

Nöromiyelitis optika (NMO) sinir sisteminde optik sinirlerin ve spinal kordun tutulumu ile karakterize idiyopatik inflamatuar demiyelinizan bir hastalıktır. Astrosit ayak çıkıntılarında bulunan bir su kanalı proteini olan aquaporin-4'e (AQP-4) karşı gelişen antikorlara bağlı meydana gelir. Seyirleri, prognozları ve tedavi yöntemlerinin farklı olması nedeni ile, NMO'yu multipl sklerozdan (MS) ve diğer demiyelinizan hastalıklardan ayırt etmek önemlidir.

🔖

Cite This Article

GÜNEŞ, H. N., ÇAKAL, B. G., YOLDAŞ, T. K. (2022). NÖROMİYELİTİS OPTİKA. Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi, Cilt: 47 - Sayı: 2, 31–36. https://ajindex.com/articles/441431

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Jarius, S. and B. Wildemann, 'Noteomielite' accompanied by acute amaurosis (1844). An early case of neuromiyelitis optica. J Neurol Sci 2012
  2. Jarius, S. and B. Wildemann, The history of neuromyelitis optica. J. Neuroinflammation 2013
  3. Jarius, S. and B. Wildemann, An early case of neuromyelitis optica: On a forgotten report by Jakob Lockhart Clarke, FRS. Mult Scler 2011
  4. Papadopoulos, M.C. and A.S. Verkman, Aquaporin water channels in the nervous system. Nat Rev Neurosci 2013
  5. Pittock, S.J., et al., Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol 2006
  6. J. Sellner, M. Boggild, M. Clanet,R.Q.Hintzen, Z.Illes, X.Montalban, R.A.DuPasquier, C. H. Polman, P. S. Sorensen and B. Hemmer. EFNS guidelines on diagnosis and management of neuromyelitis optica European Journal of Neurology 2010
  7. Wingerchuk DM, Hogancamp WF, O_Brien PC, et al. The clinical course of neuromyelitis optica (Devic_s syndrome). Neurology 1999
  8. Banwell B, Tenembaum S, Lennon VA, et al. Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders. Neurology 2008
  9. Wingerchuk DM, Weinshenker BG. Neuromyelitis optica: clinical predictors of a relapsing course and survival. Neurology 2003
  10. Merle H, Olindo S, Bonnan M, et al. Natural history of the visual impairment of relapsing neuromyelitis optica. Ophthalmology 2007
  11. de Seze J, Blanc F, Jeanjean L, et al. Optical coherence tomography in neuromyelitis optica. ArchNeurol 2008
  12. Naismith RT, Tutlam NT, Xu J, et al. Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis. Neurology 2009
  13. Pittock SJ, Lennon VA, Krecke K, et al. Brain abnormalities in neuromyelitis optica. Arch Neurol 2006
  14. Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006
  15. Neuromyelitis Optica. Mark J. Morrow, MD, Dean Wingerchuk, MD, MSc, FRCP(C) 16)Magaña SM, Matiello M, Pittock SJ, McKeon A, Lennon VA, Rabinstein AA, Shuster E, Kantarci OH, Lucchinetti CF, Weinshenker BG. Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrumdisorders. Neurology 2009
  16. Cabrera-Gomez JA, Quevedo-Sotolongo L, GonzalezQuevedo A, et al. Brain magnetic resonance imaging findings in relapsin